Grant: Discovery Grants Program - Individual
University of Toronto
$87,589.00
The microbial battlefield: characterizing the phage-host evolutionary arms race in Streptomyces
EF 2023-24
Résumé
Viral predation presents a strong evolutionary pressure on living organisms in all ecosystems. Like humans, bacteria can be infected and killed by viruses, and they encode immune systems that help defend them from these infections. These immune systems act at the single bacterial cell level and rely on proteins or protein-nucleic acid complexes to inhibit specific steps in the phage life cycle. Research performed in my laboratory uncovered a completely different class of anti-phage defence that is mediated through the activity of small chemical molecules. We showed that Streptomyces bacteria produce natural products known as secondary metabolites that powerfully inhibit the replication of diverse phages. This work provided a new biological role for secondary metabolites and a new archetype of anti-phage defence. While the role of Streptomyces secondary metabolites in defence against other cellular predators like bacteria and yeast is widely appreciated, their role in defence against the most abundant predator, phages, is very poorly understood. Thus, the goal of our work is to gain insight into how the activity of bacterial secondary metabolites shapes phage-bacterial interactions in the soil communities that Streptomyces inhabit. As many bacterially produced secondary metabolites are known to be secreted and diffuse through the surrounding environment, their production may provide a chemical defence that acts at the community level, in sharp contrast to most bacterial defence systems which act within individual cells. Our fundamental research program on Streptomyces anti-phage chemical defence will investigate the repertoire of Streptomyces secondary metabolites that mediate anti-phage defence and determine how they function. We will also determine how phages themselves influence and/or mediate control of secondary metabolite production to ensure their own survival. This work will provide the first comprehensive look at the diversity of chemical matter that mediates viral resistance and improve our understanding of the roles played by small molecules in bacterial defence. The discovery of new anti-phage compounds will also provide us with new ways to specifically interfere with phage infection that may have important applications in industrial and biotechnological processes. The bacterial cultures commonly used in recombinant pharmaceutical production, fermentation, and bioremediation processes are sensitive to phage infection, and an outbreak can lead to loss of the product at a tremendous economic cost. A broad acting anti-phage compound could have tremendous utility for these applications, protecting the bacterial cultures from phage infection, preventing spoilage of the process and mitigating economic loss.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2023-05366
Name nom
Maxwell, Karen
Department département
Biochemistry
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2023
Award amount
87589
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5202
Research subject group en
Microbiology
Research subject group fr
Virology
Research subject en
Microbiologie
Research subject fr
Virologie
Application title
The microbial battlefield: characterizing the phage-host evolutionary arms race in Streptomyces
Keyword
bacteriophage; phage; secondary metabolites; Streptomyces
Application summary
Viral predation presents a strong evolutionary pressure on living organisms in all ecosystems. Like humans, bacteria can be infected and killed by viruses, and they encode immune systems that help defend them from these infections. These immune systems act at the single bacterial cell level and rely on proteins or protein-nucleic acid complexes to inhibit specific steps in the phage life cycle. Research performed in my laboratory uncovered a completely different class of anti-phage defence that is mediated through the activity of small chemical molecules. We showed that Streptomyces bacteria produce natural products known as secondary metabolites that powerfully inhibit the replication of diverse phages. This work provided a new biological role for secondary metabolites and a new archetype of anti-phage defence. While the role of Streptomyces secondary metabolites in defence against other cellular predators like bacteria and yeast is widely appreciated, their role in defence against the most abundant predator, phages, is very poorly understood. Thus, the goal of our work is to gain insight into how the activity of bacterial secondary metabolites shapes phage-bacterial interactions in the soil communities that Streptomyces inhabit. As many bacterially produced secondary metabolites are known to be secreted and diffuse through the surrounding environment, their production may provide a chemical defence that acts at the community level, in sharp contrast to most bacterial defence systems which act within individual cells. Our fundamental research program on Streptomyces anti-phage chemical defence will investigate the repertoire of Streptomyces secondary metabolites that mediate anti-phage defence and determine how they function. We will also determine how phages themselves influence and/or mediate control of secondary metabolite production to ensure their own survival. This work will provide the first comprehensive look at the diversity of chemical matter that mediates viral resistance and improve our understanding of the roles played by small molecules in bacterial defence. The discovery of new anti-phage compounds will also provide us with new ways to specifically interfere with phage infection that may have important applications in industrial and biotechnological processes. The bacterial cultures commonly used in recombinant pharmaceutical production, fermentation, and bioremediation processes are sensitive to phage infection, and an outbreak can lead to loss of the product at a tremendous economic cost. A broad acting anti-phage compound could have tremendous utility for these applications, protecting the bacterial cultures from phage infection, preventing spoilage of the process and mitigating economic loss.